-
Clinical Ophthalmology
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Bacterial endophthalmitis following 25-gauge transconjunctival sutureless vitrectomy
Case report
(2274) Views (470) Full article downloads
Authors: Drew N Sommerville, Dean P Hainsworth
Published Date September 2008
Volume 2008:2(4) Pages 935 - 936
DOI: http://dx.doi.org/10.2147/OPTH.S2489
Drew N Sommerville, Dean P Hainsworth
The Mason Eye Institute, University of Missouri, Columbia, Missouri, USA
Purpose: To report a case of endophthalmitis following 25-gauge transconjunctival sutureless vitrectomy.
Design: Observational case report.
Methods: An 87-year-old male who underwent sutureless 25-gauge vitrectomy developed unilateral endophthalmitis. Vitreous culture revealed Staphylococcus coagulase-negative bacteria. He was subsequently treated with intravitreal antibiotics and oral prednisone.
Results: The endophthalmitis resolved with a best corrected visual acuity of 6/200 with the presence of an epiretinal membrane.
Conclusions: Possible contributing factors to endophthalmitis following sutureless vitrectomy include decreased vitreous irrigation/lavage, lack of a watertight wound, and/or vitreous wicking, all of which may promote intraocular bacterial entrance. A sutureless vitrectomy system may increase the risk of vitrectomy-associated endophthalmitis.
Keywords: endophthalmitis, 25-gauge vitrectomy, vitreous wick, sutureless, high flow lavage
- Journal Indexing
See where all the Dove Press journals are indexed
- Interested in being a peer-reviewer?
Click here to register.
- Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives
- Protection of neurons in the retinal ganglion cell layer against excitotoxicity by the N-acylethanolamine, N-linoleoylethanolamine
- A computer-based anaglyphic system for the treatment of amblyopia
- Treatment of cystoid macular edema with the new-generation NSAID nepafenac 0.1%




